Peter Marckmann
Clinical Research Unit
Department of Nephrology
Odense University Hospital
Odense
Denmark
Name/email consistency: high
- Randomized controlled trial of cholecalciferol supplementation in chronic kidney disease patients with hypovitaminosis D. Marckmann, P., Agerskov, H., Thineshkumar, S., Bladbjerg, E.M., Sidelmann, J.J., Jespersen, J., Nybo, M., Rasmussen, L.M., Hansen, D., Scholze, A. Nephrol. Dial. Transplant. (2012)
- Nephrogenic systemic fibrosis: clinical picture and treatment. Marckmann, P., Skov, L. Radiol. Clin. North Am. (2009)
- Nephrogenic systemic fibrosis: epidemiology update. Marckmann, P. Curr. Opin. Nephrol. Hypertens. (2008)
- Possibly enhanced Gd excretion in dialysate, but no major clinical benefit of 3-5 months of treatment with sodium thiosulfate in late stages of nephrogenic systemic fibrosis. Marckmann, P., Nielsen, A.H., Sloth, J.J. Nephrol. Dial. Transplant. (2008)
- Clinical manifestation of gadodiamide-related nephrogenic systemic fibrosis. Marckmann, P., Skov, L., Rossen, K., Thomsen, H.S. Clin. Nephrol. (2008)
- An epidemic outbreak of nephrogenic systemic fibrosis in a Danish hospital. Marckmann, P. Eur. J. Radiol (2008)
- Case-control study of gadodiamide-related nephrogenic systemic fibrosis. Marckmann, P., Skov, L., Rossen, K., Heaf, J.G., Thomsen, H.S. Nephrol. Dial. Transplant. (2007)
- Nephrogenic systemic fibrosis: suspected causative role of gadodiamide used for contrast-enhanced magnetic resonance imaging. Marckmann, P., Skov, L., Rossen, K., Dupont, A., Damholt, M.B., Heaf, J.G., Thomsen, H.S. J. Am. Soc. Nephrol. (2006)